cGMP may have trophic effects on beta cell function comparable to those of cAMP, implying a role for high-dose biotin in prevention/treatment of diabetes

Medical Hypotheses

Volumn 66, Issue 2, 2006, Pages 323-328

  McCarty, Mark F ^a,b  

^a NutriGuard Research   (United States)

^b Natural Alternatives International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; CYCLIC AMP; CYCLIC GMP; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GUANYLATE CYCLASE; INCRETIN; INSULIN; NITRIC OXIDE; TRANSCRIPTION FACTOR PDX 1;

APOPTOSIS; CELL DIFFERENTIATION; CELL FUNCTION; COMPARATIVE STUDY; DIABETES MELLITUS; DRUG MEGADOSE; ENZYME ACTIVATION; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; MUSCLE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

RODENTIA;

EID: 28844440831     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.04.031     Document Type: Article

References (79)

1. J.F. Habener The incretin notion and its relevance to diabetes Endocrinol Metab Clin North Am 22 1993 775 794
2. J.C. Marie, G. Rosselin, and G. Skoglund Pancreatic beta-cell receptors and G proteins coupled to adenylyl cyclase Ann N Y Acad Sci 805 1996 122 131
3. R.W. Gelling, M.B. Wheeler, J. Xue, S. Gyomorey, C. Nian, and R.A. Pederson Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor Endocrinology 138 1997 2640 2643
4. M. Hallbrink, T. Holmqvist, M. Olsson, C.G. Ostenson, S. Efendic, and U. Langel Different domains in the third intracellular loop of the GLP-1 receptor are responsible for Galpha (s) and Galpha (i)/Galpha (o) activation Biochim Biophys Acta 1546 2001 79 86
5. B. Thorens, and G. Waeber Glucagon-like peptide-I and the control of insulin secretion in the normal state and in NIDDM Diabetes 42 1993 1219 1225
6. P.E. MacDonald, W. El Kholy, M.J. Riedel, A.M. Salapatek, P.E. Light, and M.B. Wheeler The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion Diabetes 51 Suppl 3 2002 S434 S442
7. F.M. Matschinsky Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes Diabetes 39 1990 647 652
8. Y. Wang, R. Perfetti, N.H. Greig, H.W. Holloway, K.A. DeOre, and C. Montrose-Rafizadeh Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats J Clin Invest 99 1997 2883 2889
9. X. Wang, C.M. Cahill, M.A. Pineyro, J. Zhou, M.E. Doyle, and J.M. Egan Glucagon-like peptide-1 regulates the beta cell transcription factor, PDX-1, in insulinoma cells Endocrinology 140 1999 4904 4907
10. X. Wang, J. Zhou, M.E. Doyle, and J.M. Egan Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism Endocrinology 142 2001 1820 1827
11. J. Zhou, M.A. Pineyro, X. Wang, M.E. Doyle, and J.M. Egan Exendin-4 differentiation of a human pancreatic duct cell line into endocrine cells: involvement of PDX-1 and HNF3beta transcription factors J Cell Physiol 192 2002 304 314
12. D.A. Stoffers, T.J. Kieffer, M.A. Hussain, D.J. Drucker, S. Bonner-Weir, and J.F. Habener Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas Diabetes 49 2000 741 748
13. E.J. Abraham, C.A. Leech, J.C. Lin, H. Zulewski, and J.F. Habener Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells Endocrinology 143 2002 3152 3161
14. G. Waeber, N. Thompson, P. Nicod, and C. Bonny Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor Mol Endocrinol 10 1996 1327 1334
15. S. Gremlich, C. Bonny, G. Waeber, and B. Thorens Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels J Biol Chem 272 1997 30261 30269
16. S. Yoshida, Y. Kajimoto, T. Yasuda, H. Watada, Y. Fujitani, and H. Kosaka PDX-1 induces differentiation of intestinal epithelioid IEC-6 into insulin-producing cells Diabetes 51 2002 2505 2513
17. Y. Lee, H. Hirose, M. Ohneda, J.H. Johnson, J.D. McGarry, and R.H. Unger Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships Proc Natl Acad Sci USA 91 1994 10878 10882
18. R.H. Unger Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications Diabetes 44 1995 863 870
19. R. Roduit, J. Morin, F. Masse, L. Segall, E. Roche, and C.B. Newgard Glucose down-regulates the expression of the peroxisome proliferator-activated receptor-alpha gene in the pancreatic beta -cell J Biol Chem 275 2000 35799 35806
20. W. El Assaad, J. Buteau, M.L. Peyot, C. Nolan, R. Roduit, and S. Hardy Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death Endocrinology 144 2003 4154 4163
21. M. Prentki, E. Joly, W. El Assaad, and R. Roduit Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes Diabetes 51 Suppl 3 2002 S405 S413
22. L.K. Olson, A. Sharma, M. Peshavaria, C.V. Wright, H.C. Towle, and R.P. Rodertson Reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to a supraphysiologic glucose concentration is associated with loss of STF-1 transcription factor expression Proc Natl Acad Sci USA 92 1995 9127 9131
23. D.H. Zangen, S. Bonner-Weir, C.H. Lee, J.B. Latimer, C.P. Miller, and J.F. Habener Reduced insulin, GLUT2, and IDX-1 in beta-cells after partial pancreatectomy Diabetes 46 1997 258 264
24. J. Seufert, G.C. Weir, and J.F. Habener Differential expression of the insulin gene transcriptional repressor CCAAT/enhancer-binding protein beta and transactivator islet duodenum homeobox-1 in rat pancreatic beta cells during the development of diabetes mellitus J Clin Invest 101 1998 2528 2539
25. D.J. Drucker Enhancing incretin action for the treatment of type 2 diabetes Diabetes Care 26 2003 2929 2940
26. V.A. Gault, P.R. Flatt, and F.P. O'Harte Glucose-dependent insulinotropic polypeptide analogues and their therapeutic potential for the treatment of obesity-diabetes Biochem Biophys Res Commun 308 2003 207 213
27. B. Ahren Gut peptides and type 2 diabetes mellitus treatment Curr Diab Rep 3 2003 365 372
28. A.C. Loweth, G.T. Williams, J.H. Scarpello, and N.G. Morgan Heterotrimeric G-proteins are implicated in the regulation of apoptosis in pancreatic beta-cells Exp Cell Res 229 1996 69 76
29. H. Hui, A. Nourparvar, X. Zhao, and R. Perfetti Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway Endocrinology 144 2003 1444 1455
30. U.S. Jhala, G. Canettieri, R.A. Screaton, R.N. Kulkarni, S. Krajewski, and J. Reed cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2 Genes Dev 17 2003 1575 1580
31. G. Kwon, K.L. Pappan, C.A. Marshall, J.E. Schaffer, and M.L. McDaniel Cyclic AMP dose-dependently prevents palmitate-induced apoptosis by both PKA- and cAMP-GEF-dependent pathways in beta -cells J Biol Chem 2003
32. R. Lupi, F. Dotta, L. Marselli, S. Del Guerra, M. Masini, and C. Santangelo Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated Diabetes 51 2002 1437 1442
33. S. Piro, M. Anello, C. Di Pietro, M.N. Lizzio, G. Patane, and A.M. Rabuazzo Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress Metabolism 51 2002 1340 1347
34. H.H. Schmidt, T.D. Warner, K. Ishii, H. Sheng, and F. Murad Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides Science 255 1992 721 723
35. S.R. Smukler, L. Tang, M.B. Wheeler, and A.M. Salapatek Exogenous nitric oxide and endogenous glucose-stimulated beta-cell nitric oxide augment insulin release Diabetes 51 2002 3450 3460
36. C.J. Hedeskov Mechanism of glucose-induced insulin secretion Physiol Rev 60 1980 442 509
37. N. Matsuura, T. Ishikawa, S. Abe, H. Yuyama, F. Sugino, and K. Ishii Nitric oxide-cyclic GMP system potentiates glucose-induced rise in cytosolic Ca2+ concentration in rat pancreatic beta-cells Life Sci 65 1999 1515 1522
38. T. Ishikawa, Y. Kaneko, F. Sugino, and K. Nakayama Two distinct effects of cGMP on cytosolic Ca2+ concentration of rat pancreatic beta-cells J Pharmacol Sci 91 2003 41 46
39. Y. Kaneko, T. Ishikawa, S. Amano, and K. Nakayama Dual effect of nitric oxide on cytosolic Ca2+ concentration and insulin secretion in rat pancreatic beta-cells Am J Physiol Cell Physiol 284 2003 C1215 C1222
40. H. Yoshikawa, Y. Tajiri, Y. Sako, T. Hashimoto, F. Umeda, and H. Nawata Effects of biotin on glucotoxicity or lipotoxicity in rat pancreatic islets Metabolism 51 2002 163 168
41. L. Gunther, P.O. Berberat, M. Haga, S. Brouard, R.N. Smith, and M.P. Soares Carbon monoxide protects pancreatic beta-cells from apoptosis and improves islet function/survival after transplantation Diabetes 51 2002 994 999
42. D.L. Vesely Biotin enhances guanylate cyclase activity Science 216 1982 1329 1330
43. J.T. Spence, and A.P. Koudelka Effects of biotin upon the intracellular level of cGMP and the activity of glucokinase in cultured rat hepatocytes J Biol Chem 259 1984 6393 6396
44. I.N. Singh, and K. Dakshinamurti Stimulation of guanylate cyclase and RNA polymerase II activities in HeLa cells and fibroblasts by biotin Mol Cell Biochem 79 1988 47 55
45. P. Borboni, R. Magnaterra, R.A. Rabini, R. Staffolani, O. Porzio, and G. Sesti Effect of biotin on glucokinase activity, mRNA expression and insulin release in cultured beta-cells Acta Diabetol 33 1996 154 158
46. G. Romero-Navarro, G. Cabrera-Valladares, M.S. German, F.M. Matschinsky, A. Velazquez, and J. Wang Biotin regulation of pancreatic glucokinase and insulin in primary cultured rat islets and in biotin-deficient rats Endocrinology 140 1999 4595 4600
47. Y. Furukawa Enhancement of glucose-induced insulin secretion and modification of glucose metabolism by biotin Nippon Rinsho 57 1999 2261 2269
48. H. Sone, M. Ito, M. Shimizu, Y. Sasaki, M. Komai, and Y. Furukawa Characteristics of the biotin enhancement of glucose-induced insulin release in pancreatic islets of the rat Biosci Biotechnol Biochem 64 2000 550 554
49. M. Maebashi, Y. Makino, and Y. Furukawa Therapeutic evaluation of the effect of biotin on hyperglycemia in patients with non-insulin-dependent diabetes mellitus J Clin Biochem Nutr 14 1993 211 218
50. J.T. Spence, M.J. Merrill, and H.C. Pitot Role of insulin, glucose, and cyclic GMP in the regulation of glucokinase in cultured hepatocytes J Biol Chem 256 1981 1598 1603
51. J.P. Skala, P. Hahn, and B.L. Knight Effect of insulin and prednisolone on cyclic nucleotides and phosphoenolpyruvate carboxykinase activity in brown fat and liver of developing rats Biochim Biophys Acta 631 1980 420 427
52. K. Dakshinamurti, and W. Li Transcriptional regulation of liver phosphoenolpyruvate carboxykinase by biotin in diabetic rats Mol Cell Biochem 132 1994 127 132
53. J.C. Coggeshall, J.P. Heggers, M.C. Robson, and H. Baker Biotin status and plasma glucose in diabetics Ann NY Acad Sci 447 1985 387 392
54. A. Reddi, B. DeAngelis, O. Frank, N. Lasker, and H. Baker Biotin supplementation improves glucose and insulin tolerances in genetically diabetic KK mice Life Sci 42 1988 1323 1330
55. H. Zhang, K. Osada, M. Maebashi, M. Ito, M. Komai, and Y. Furukawa A high biotin diet improves the impaired glucose tolerance of long-term spontaneously hyperglycemic rats with non-insulin-dependent diabetes mellitus J Nutr Sci Vitaminol (Tokyo) 42 1996 517 526
56. H. Zhang, K. Osada, H. Sone, and Y. Furukawa Biotin administration improves the impaired glucose tolerance of streptozotocin-induced diabetic Wistar rats J Nutr Sci Vitaminol (Tokyo) 43 1997 271 280
57. D.G. Hardie AMP-activated protein kinase: a key system mediating metabolic responses to exercise Med Sci Sports Exerc 36 2004 28 34
58. H.A. Koistinen, D. Galuska, A.V. Chibalin, J. Yang, J.R. Zierath, and G.D. Holman 5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes Diabetes 52 2003 1066 1072
59. L.G. Fryer, E. Hajduch, F. Rencurel, I.P. Salt, H.S. Hundal, and D.G. Hardie Activation of glucose transport by AMP-activated protein kinase via stimulation of nitric oxide synthase Diabetes 49 2000 1978 1985
60. G.J. Etgen Jr., D.A. Fryburg, and E.M. Gibbs Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway Diabetes 46 1997 1915 1919
61. E. Nisoli, E. Clementi, C. Paolucci, V. Cozzi, C. Tonello, and C. Sciorati Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide Science 299 2003 896 899
62. L.F. Michael, Z. Wu, R.B. Cheatham, P. Puigserver, G. Adelmant, and J.J. Lehman Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1 Proc Natl Acad Sci U S A 98 2001 3820 3825
63. K. Baar, A.R. Wende, T.E. Jones, M. Marison, L.A. Nolte, and M. Chen Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1 FASEB J 16 2002 1879 1886
64. M.W. Radomski, and S. Moncada The biological and pharmacological role of nitric oxide in platelet function Adv Exp Med Biol 344 1993 251 264
65. A. Wennmalm Nitric oxide (NO) in the cardiovascular system: role in atherosclerosis and hypercholesterolemia Blood Press 3 1994 279 282
66. L.J. Ignarro, G. Cirino, A. Casini, and C. Napoli Nitric oxide as a signaling molecule in the vascular system: an overview J Cardiovasc Pharmacol 34 1999 879 886
67. M.T. Gewaltig, and G. Kojda Vasoprotection by nitric oxide: mechanisms and therapeutic potential Cardiovasc Res 55 2002 250 260
68. B.C. Kone Molecular biology of natriuretic peptides and nitric oxide synthases Cardiovasc Res 51 2001 429 441
69. H. Hayakawa, and L. Raij The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension Hypertension 29 1997 235 241
70. A. Bataineh, and L. Raij Angiotensin II, nitric oxide, and end-organ damage in hypertension Kidney Int Suppl 68 1998 S14 S19
71. M.J. Stevens, J. Dananberg, E.L. Feldman, S.A. Lattimer, M. Kamijo, and T.P. Thomas The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat J Clin Invest 94 1994 853 859
72. M.J. Stevens, E.L. Feldman, and D.A. Greene The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects Diabet Med 12 1995 566 579
73. D. Koutsikos, B. Agroyannis, and H. Tzanatos-Exarchou Biotin for diabetic peripheral neuropathy Biomed Pharmacother 44 1990 511 514
74. C. Epps-Fung, J.P. Williams, T.L. Cornwell, T.M. Lincoln, J.M. McDonald, and W. Radding Regulation of osteoclastic acid secretion by cGMP-dependent protein kinase Biochem Biophys Res Commun 204 1994 565 571
75. L.S. Holliday, A.D. Dean, R.H. Lin, J.E. Greenwald, and S.L. Gluck Low NO concentrations inhibit osteoclast formation in mouse marrow cultures by cGMP-dependent mechanism Am J Physiol 272 1997 F283 F291
76. S.S. Dong, J.P. Williams, S.E. Jordan, T. Cornwell, and H.C. Blair Nitric oxide regulation of cGMP production in osteoclasts J Cell Biochem 73 1999 478 487
77. J. Garcia-Villafranca, A. Guillen, and J. Castro Involvement of nitric oxide/cyclic GMP signaling pathway in the regulation of fatty acid metabolism in rat hepatocytes Biochem Pharmacol 65 2003 807 812
78. M. Nakane Soluble guanylyl cyclase: physiological role as an NO receptor and the potential molecular target for therapeutic application Clin Chem.Lab Med 41 2003 865 870
79. D.M. Mock Biotin E.E. Ziegler L.J. Filer Jr. Present Knowledge in Nutrition seventh ed. 1996 ILSI Press Washington,D.C. 220 235